Does SACITUZUMAB GOVITECAN Cause Alopecia? 38 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 38 reports of Alopecia have been filed in association with SACITUZUMAB GOVITECAN (TRODELVY). This represents 3.0% of all adverse event reports for SACITUZUMAB GOVITECAN.
38
Reports of Alopecia with SACITUZUMAB GOVITECAN
3.0%
of all SACITUZUMAB GOVITECAN reports
3
Deaths
7
Hospitalizations
How Dangerous Is Alopecia From SACITUZUMAB GOVITECAN?
Of the 38 reports, 3 (7.9%) resulted in death, 7 (18.4%) required hospitalization.
Is Alopecia Listed in the Official Label?
Yes, Alopecia is listed as a known adverse reaction in the official FDA drug label for SACITUZUMAB GOVITECAN.
What Other Side Effects Does SACITUZUMAB GOVITECAN Cause?
Disease progression (389)
Diarrhoea (184)
Death (182)
Inappropriate schedule of product administration (147)
Neutropenia (128)
Off label use (111)
Fatigue (109)
Febrile neutropenia (92)
Asthenia (90)
Weight decreased (89)
What Other Drugs Cause Alopecia?
DOCETAXEL (29,347)
METHOTREXATE (14,360)
ADALIMUMAB (13,726)
ETANERCEPT (11,390)
INFLIXIMAB (10,374)
LEFLUNOMIDE (10,267)
RITUXIMAB (10,119)
ABATACEPT (10,043)
TOCILIZUMAB (9,680)
HYDROXYCHLOROQUINE (9,653)
Which SACITUZUMAB GOVITECAN Alternatives Have Lower Alopecia Risk?
SACITUZUMAB GOVITECAN vs SACITUZUMAB GOVITECAN-HZIY
SACITUZUMAB GOVITECAN vs SACROSIDASE
SACITUZUMAB GOVITECAN vs SACUBITRIL
SACITUZUMAB GOVITECAN vs SACUBITRIL\VALSARTAN
SACITUZUMAB GOVITECAN vs SAFINAMIDE